Dietary Supplement Programs

DEA puts kratom on schedule 1 drugs list

02-Sep-2016 By Hank Schultz

The Drug Enforcement Administration has put mitragynine and 7-hydroxymitragynine, the active constituents of kratom, on its list of schedule 1 banned drugs, a list that includes heroin and LSD.

FDA’s Welch: ‘We are not seeing the drastic jumps in GMP compliance that we would like to see’

15-Oct-2015 By Stephen Daniells

With about 50% of the industry's facilities inspected, GMP compliance is largely not where the FDA would want it to be, said the Agency's Dr Cara Welch.

GMP inspections could focus on Utah, California

20-Jan-2009 By Lorraine Heller

The focus of FDA’s GMP inspections of dietary supplement manufacturing facilities will likely take a short-term focus on the Utah area and Southern California, according to inside sources.

Webinar to examine NDI notification process

31-Oct-2008

A webinar to be held in December will provide manufacturers with guidance on how to file a new dietary ingredient (NDI) notification, from both a legal and market perspective.